Evidence map›Paper›PMID 29656860›Full record

ArticleAmerican journal of human genetics2018

Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.

Hanyin Cheng, Avinash V Dharmadhikari, Sylvia Varland, Ning Ma, Deepti Domingo, Robert Kleyner, Alan F Rope, Margaret Yoon, Asbjørg Stray-Pedersen, Jennifer E Posey and 62 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Neuroanatomical features of NAA10 and NAA15-related neurodevelopmental syndromes.Journal of neuroradiology = Journal de neuroradiologie · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Acetyltransferase in cardiovascular disease and aging.The journal of cardiovascular aging · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

72 authors at 20 institutions in 9 countries.

Hanyin ChengBaylor Genetics, Houston, TX, 77021, USA.
Avinash V DharmadhikariBaylor Genetics, Houston, TX, 77021, USA.
Sylvia VarlandDepartment of Biomedicine, University of Bergen, N-5020 Bergen, Norway; Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway.
Ning MaStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Deepti DomingoSchool of Biological Sciences, Faculty of Genes and Evolution, the University of Adelaide, Adelaide, SA 5000, Australia.
Robert KleynerStanley Institute for Cognitive Genomics, 1Bungtown Road, Cold Spring Harbor Laboratory, NY 11724, USA.
Alan F RopeDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, OR 97227, USA.
Margaret YoonStanley Institute for Cognitive Genomics, 1Bungtown Road, Cold Spring Harbor Laboratory, NY 11724, USA.
Asbjørg Stray-PedersenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, N-0424 Oslo, and Institute of Clinical Medicine, University of Oslo, N-0318 Oslo, Norway.
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Sarah R CrewsDepartment of Pharmacology, Creighton University Medical School, Omaha, NE, 68178, USA.
Mohammad K EldomeryDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Zeynep Coban AkdemirDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Andrea M LewisDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX 77030, USA.
Vernon R SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Erin ConboyDepartment of Clinical Genomics, Mayo Clinic, MN 55905, USA.
Katherine AgreDepartment of Clinical Genomics, Mayo Clinic, MN 55905, USA.
Fan XiaBaylor Genetics, Houston, TX, 77021, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Magdalena WalkiewiczBaylor Genetics, Houston, TX, 77021, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; The National Institute of Allergy and Infectious Disease, The National Institutes of Health, Bethesda, MD 20892, USA.
Mauro LongoniPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Surgery, Harvard Medical School, Boston, MA 02114, USA.
Frances A HighPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Pediatrics, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Marjon A van SlegtenhorstDepartment of Clinical Genetics, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.
Candice R FinnilaHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
Arie van HaeringenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, 2333, The Netherlands.
Nicolette den HollanderDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, 2333, The Netherlands.
Claudia RuivenkampDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, 2333, The Netherlands.
Sakkubai NaiduKennedy Krieger Institute, 801 North Broadway Baltimore, MD 21205, USA.
Sonal MahidaKennedy Krieger Institute, 801 North Broadway Baltimore, MD 21205, USA.
Elizabeth E PalmerGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia; School of Women's and Children's Health, University of New South Wales, Sydney, NSW 2031, Australia.
Lucinda MurrayGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW 2298, Australia.
Derek LimWest Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2TG, UK.
Parul JayakarDivision of Genetics and Metabolism, Nicklaus Children's Hospital, Miami, FL 33155, USA.
Michael J ParkerSheffield Clinical Genetics Service, Sheffield Children's Hospital, Western Bank, Sheffield S10 2TH, UK.
Stefania GiustoOasi Research Institute - Istituto di Ricovero e Cura a Carattere Scientifico, Troina 94018, Italy.
Emanuela StracuzziOasi Research Institute - Istituto di Ricovero e Cura a Carattere Scientifico, Troina 94018, Italy.
Corrado RomanoOasi Research Institute - Istituto di Ricovero e Cura a Carattere Scientifico, Troina 94018, Italy.
Jennifer S BeighleyDepartment of Psychiatry, University of Washington, Seattle WA, 98195, USA.
Raphael A BernierDepartment of Psychiatry, University of Washington, Seattle WA, 98195, USA.
Sébastien KüryDepartment of Medical Genetics, Centre Hospitalier Universitaire, Nantes 44093, France.
Mathilde NizonDepartment of Medical Genetics, Centre Hospitalier Universitaire, Nantes 44093, France.
Mark A CorbettAdelaide Medical School and Robinson Research Institute, the University of Adelaide, Adelaide, SA 5000, Australia.
Marie ShawAdelaide Medical School and Robinson Research Institute, the University of Adelaide, Adelaide, SA 5000, Australia.
Alison GardnerAdelaide Medical School and Robinson Research Institute, the University of Adelaide, Adelaide, SA 5000, Australia.
Christopher BarnettPaediatric and Reproductive Genetics, South Australian Clinical Genetics Service, SA Pathology (at Women's and Children's Hospital), Adelaide, SA 5006, Australia.
Ruth ArmstrongEast Anglian Medical Genetics Service, Clinical Genetics, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Karin S KassahnDepartment of Genetics and Molecular Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, SA 5006, Australia; School of Biological Sciences, University of Adelaide, Adelaide, SA 5000, Australia.
Anke Van DijckDepartment of Medical Genetics, University of Antwerp, Antwerp 2000, Belgium.
Geert VandeweyerDepartment of Medical Genetics, University of Antwerp, Antwerp 2000, Belgium.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Jolanda SchievingDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Marjolijn J JongmansDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Bert B A de VriesDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Bronwyn KerrManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK; Division of Evolution and Genomic Sciences School of Biological Sciences, University of Manchester, Manchester M13 9PL, UK.
Samantha K RojasChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Richard PersonGeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
Rebecca WillaertGeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
R Frank KooyDepartment of Medical Genetics, University of Antwerp, Antwerp 2000, Belgium.
Yaping YangBaylor Genetics, Houston, TX, 77021, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Joseph C WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center of Baylor College of Medicine, Houston, TX 77030, USA.
Thomas ArnesenDepartment of Biomedicine, University of Bergen, N-5020 Bergen, Norway; Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway; Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway.
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.
Wendy K ChungDepartments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY 10032, USA.
Jozef GeczSchool of Biological Sciences, Faculty of Genes and Evolution, the University of Adelaide, Adelaide, SA 5000, Australia; Adelaide Medical School and Robinson Research Institute, the University of Adelaide, Adelaide, SA 5000, Australia; Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
Holly A F StessmanDepartment of Pharmacology, Creighton University Medical School, Omaha, NE, 68178, USA.
Linyan MengBaylor Genetics, Houston, TX, 77021, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: lmeng@bcm.edu.
Gholson J LyonStanley Institute for Cognitive Genomics, 1Bungtown Road, Cold Spring Harbor Laboratory, NY 11724, USA. Electronic address: gholsonjlyon@gmail.com.
Baylor College of Medicine · USBaylor Genetics · USUniversity of Adelaide · AUCold Spring Harbor Laboratory · USLeiden University Medical Center · NLOasi Maria SS · ITRadboud University Medical Center · NLUniversity of Antwerp · BEUniversity of Washington · USCentre Hospitalier Universitaire de Nantes · FRCreighton University · USErasmus MC · NLHudsonAlpha Institute for Biotechnology · USKennedy Krieger Institute · USMayo Clinic in Florida · USRadboud University Nijmegen · NLSouth Australia Pathology · AUAddenbrooke's Hospital · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCardiovascular Institute of the South · US

Funding

THE DROSOPHILA GENETICS AND RNAI CORE (THE FLY CORE)P01HD068250 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, WENDY K, DONAHOE, PATRICIA K · 2011 to 2022
$17.1M
Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Genomic Diagnosis in Children with Developmental DelayUM1HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COOPER, GREGORY MICHAEL, MYERS, RICHARD M · 2013 to 2016
$7.5M
Amino-terminal acetylation of proteins in mammalian biology and diseaseR35GM133408 · NIGMS · INSTITUTE FOR BASIC RES IN DEV DISABIL · PI LYON, GHOLSON · 2019 to 2023
$2.4M
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset diseaseK08HG008986 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI POSEY, JENNIFER ELLEN · 2017 to 2021
$831k
NHGRI NIH HHS K08 HG008986NHGRI NIH HHS U01 HG007301NHGRI NIH HHS UM1 HG006542NHGRI NIH HHS UM1 HG007301NICHD NIH HHS P01 HD068250NICHD NIH HHS U54 HD083091NIGMS NIH HHS R35 GM133408NIMH NIH HHS R01 MH101221Wellcome Trust
6 · The paper itself

Abstract

N-alpha-acetylation is a common co-translational protein modification that is essential for normal cell function in humans. We previously identified the genetic basis of an X-linked infantile lethal Mendelian disorder involving a c.109T>C (p.Ser37Pro) missense variant in NAA10, which encodes the catalytic subunit of the N-terminal acetyltransferase A (NatA) complex. The auxiliary subunit of the NatA complex, NAA15, is the dimeric binding partner for NAA10. Through a genotype-first approach with whole-exome or genome sequencing (WES/WGS) and targeted sequencing analysis, we identified and phenotypically characterized 38 individuals from 33 unrelated families with 25 different de novo or inherited, dominantly acting likely gene disrupting (LGD) variants in NAA15. Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder. Additionally, mild craniofacial dysmorphology, congenital cardiac anomalies, and seizures are present in some subjects. RNA analysis in cell lines from two individuals showed degradation of the transcripts with LGD variants, probably as a result of nonsense-mediated decay. Functional assays in yeast confirmed a deleterious effect for two of the LGD variants in NAA15. Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth. We propose that defects in NatA-mediated N-terminal acetylation (NTA) lead to variable levels of neurodevelopmental disorders in humans, supporting the importance of the NatA complex in normal human development.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationAbnormalities, MultipleAdolescentAdultAutism Spectrum DisorderCell LineChildExonsFemaleGene Expression RegulationHumansIntellectual DisabilityMaleMiddle AgedMutationNAA15 protein, humanN-Terminal Acetyltransferase AN-Terminal Acetyltransferase ERNA, Messengerautismcongenital heart defectsintellectual disabilityNAA10NAA15NatA complexneurodevelopmental disorderN-terminal acetylation (NTA)N-terminal acetyltransferases (NATs)Ogden syndrome

Identifiers

PMID29656860
PMCPMC5986698
OpenAlexW2797831397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.